TRIUMF Celebrates New Five-Year Plan

The scientific community at TRIUMF (CSA CSM) recently gathered at its Advanced Rare Isotope Laboratory to celebrate the new Five-Year Plan for 2020-2025. It defines both the vision and mission for Canada’s particle accelerator center, communicating the lab’s goals and strategies while laying out an action plan for the specified cycle and beyond.

“For five decades, TRIUMF has delivered discovery, innovation and impact,” says Dr. Jonathan Bagger, TRIUMF director. “We have a proven track record of improving the lives of Canadians and building a better world. This plan builds on our legacy and propels us towards our future—not just for the next five years but for years and decades to come.”

TRIUMF, Canada’s particle accelerator center, is poised to enter one of the most exciting and transformative eras in its history, according to Dr. Digvir Jayas, chair of TRIUMF’s board of management. “Collectively, we have created, and are continuing to strengthen, a diverse and inclusive hub that transcends boundaries and fosters intersections of people, ideas, perspectives, disciplines, and sectors, all collaborating in the pursuit of world-class science,” he says. “Fifty years into TRIUMF’s story, I’m proud of everything we’ve accomplished so far and excited about the next chapter in our story.”

Hard choices had to be made, according to TRIUMF, but the agency refers to the final result as ambitious, achievable and fully consistent with the its vision, mission and values. The TRIUMF plan leverages past investments by the Canadian government and builds on the laboratory’s brand and global network to deliver a new level of science, training and innovation for decades to come.

To achieve these objectives, TRIUMF says its new plan invests in three critical dimensions, including science and technology seizing opportunities and expanding frontiers; a people and skills focus on developing talent and increasing access and equity; and innovation and collaboration that connects science to society and Canada to the world.

TRIUMF’s also plans to launch and converge three new platforms. This includes revolutionizing the study of isotopes for science, medicine and business through the Advanced Rare Isotope Laboratory; conducting advanced isotope research and development through the Institute for Advanced Medical Isotopes; and translating scientific discovery into commercial opportunities with TRIUMF innovations

Together, TRIUMF says these platforms will transform the agency into a global multidisciplinary hub, anchored by world-leading isotope science and ignited by the creative and innovative spirits of talented Canadians.